cro.directory
← Compare landing

HitGen Inc. vs R2M Pharma, Inc.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryHitGen Inc.R2M Pharma, Inc.
SummaryHitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.R2M Pharma is a medicinal chemistry CRO specializing in small-molecule drug discovery and preclinical development, from hit validation through GLP toxicology studies.
Services
  • Discovery Research
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • Bioanalysis
  • Analytical Method Development & Validation
  • Genomics & Sequencing Services
  • Bioinformatics & Data Science
  • Oligonucleotide Manufacturing
  • Discovery Research
  • Medicinal Chemistry
  • GLP Toxicology
Modalities
  • Small Molecule
  • Oligonucleotide
  • Peptide
  • Small Molecule
Indications
  • Oncology
  • Immunology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Ophthalmology
Data not yet provided.
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing modelsData not yet provided.
  • Functional Service Provider (FSP)
Locations
  • Houston, Houston, United States
  • Headquarters, Chengdu, China
  • Cambridge, Cambridge, United Kingdom
  • Headquarters, South San Francisco, CA, USA
CertificationsData not yet provided.Data not yet provided.

Find similar companies

HitGen Inc. alternatives · R2M Pharma, Inc. alternatives

Markdown mirror: /compare/hitgen/r2mpharma.md